 |
 |
 |
 |
|
|
|
|
 |
|
|
 |
|
|
|
|
| |
|||||||||||||||||
|
|
|
|
|
|
|
|||||||||||
|
|||||||||||||||||
|
EID
Home | Ahead of Print | Past
Issues | EID Search | Contact
Us | Announcements | Suggested
Citation | Submit Manuscript
Volume 11, Number 6, June 2005 Rifampicin Resistance in Tuberculosis Outbreak, London, EnglandClaire Jenkins,* Alleyna P. Claxton,† Robert J. Shorten,* Timothy
D. McHugh,* and Stephen H. Gillespie* |
|
|
|
 |
|
| Back to article | |
|
Figure 2. Suggested epidemiologic relationship between 6 cases of multidrug-resistant tuberculosis (MDR-TB). Resistance to rifampicin developed in patients 018, 483, and 915 while on therapy, whereas patients T7, 604, and 317 contracted primary MDR-TB. The type of mutation present in each patient's strain of MDR-TB is highlighted in bold. |
|
|
|
|
|
EID Home | Top of Page | Ahead-of-Print | Past Issues | Suggested Citation | EID Search | Contact Us | Accessibility | Privacy Policy Notice | CDC Home | CDC Search | Health Topics A-Z |
|
|
This page last reviewed May 18, 2005 |
|
|
Emerging
Infectious Diseases Journal |
|